Metastasis suppressory agents

Details Metastasis suppressory agents Metastasis suppressory agents

1996-11-15

1999-11-16

Goldberg, Jerome D.

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Radical -xh acid, or anhydride, acid halide or salt thereof...

A61K 3119

Patent

active

059859245

ABSTRACT:
The present invention provides novel metastasis suppressory agents with a lowered degree of toxicity, comprising ursolic acid or its salt as an active ingredient, which can be administered to patients per os or through injection, thus enabling the patients to receive post-operative ambulatory treatment.

REFERENCES:
Cancer Letters, Vol. 94, No. 2, 1995, pp. 213-218, Kyung-Hee Sohn et al., "Anti-angiogenic activity of triterpene acids".
Br. J. of Cancer, Vol, 72, No. 2, Oct. 1995, pp. 257-267. CT Baillie et al., "Tumour vasculature --a potential therapeutic target".
Ann. N.Y. Acad. Science Vol. 732, Sep. 6, 1994, pp. 263-272, Eric P. Sipos et al., "Inhibition of Tumor Angiogenesis".

Affiliated with

Also associated with

Rating

Metastasis suppressory agents does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Metastasis suppressory agents, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Metastasis suppressory agents will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1325361